These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15631167)

  • 21. Phosphate binders in a European haemodialysis population.
    Jean G; Vanel T
    Nephrol Dial Transplant; 2011 Jun; 26(6):2057-8; author reply 2058. PubMed ID: 21414974
    [No Abstract]   [Full Text] [Related]  

  • 22. Vascular calcification in chronic haemodialysis patients.
    Susalit E
    Acta Med Indones; 2008 Oct; 40(4):177. PubMed ID: 19530366
    [No Abstract]   [Full Text] [Related]  

  • 23. [Arteriosclerosis and vascular calcification in chronic kidney disease (CKD) patients].
    Masho Y; Shigematsu T
    Clin Calcium; 2007 Mar; 17(3):354-9. PubMed ID: 17339739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular calcification and increased mortality in dialysis patients: Is the baroreflex sensitivity the answer?
    Zitt E; Rosenkranz AR
    Nephrol Dial Transplant; 2005 Nov; 20(11):2580. PubMed ID: 16091373
    [No Abstract]   [Full Text] [Related]  

  • 25. Phosphate binders: hold the calcium?
    Bushinsky DA
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):695-6. PubMed ID: 17699274
    [No Abstract]   [Full Text] [Related]  

  • 26. Progression of vascular calcification increases QT interval in haemodialysis patients.
    Di Iorio BR; D'Avanzo E; Piscopo C; Grimaldi P; Cucciniello E; Cillo N; Bellizzi V
    Nephrol Dial Transplant; 2006 Dec; 21(12):3609-10. PubMed ID: 16880182
    [No Abstract]   [Full Text] [Related]  

  • 27. [Functional disorder of the parathyroid gland and vascular calcification in hemodialysis patients].
    Nakanishi S; Fukagawa M
    Clin Calcium; 2005 Jul; 15(7):119-23. PubMed ID: 15995307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of factors promoting vascular calcinosis in long-term hemodialysis patients].
    Renaud H; Attik H; Hervé M; Benelmouffok S; Galy C; Kambia B; Morinière P; Fournier A
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1696-700. PubMed ID: 3938242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium-based phosphate binders are appropriate in chronic renal failure.
    Friedman EA
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):704-9. PubMed ID: 17699276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thirty-month follow-up of coronary artery calcification in hemodialysis patients: different roles for inflammation and abnormal calcium-phosphorous metabolism?
    Patsalas S; Eleftheriadis T; Spaia S; Theodoroglou H; Antoniadi G; Liakopoulos V; Passadakis P; Vayonas G; Vargemezis V
    Ren Fail; 2007; 29(5):623-9. PubMed ID: 17654327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis.
    Shroff RC; McNair R; Figg N; Skepper JN; Schurgers L; Gupta A; Hiorns M; Donald AE; Deanfield J; Rees L; Shanahan CM
    Circulation; 2008 Oct; 118(17):1748-57. PubMed ID: 18838561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of arterial calcification: spotlight on the inhibitors.
    Weissen-Plenz G; Nitschke Y; Rutsch F
    Adv Clin Chem; 2008; 46():263-93. PubMed ID: 19004192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of abnormal phosphorus metabolism in the progression of chronic kidney disease and metastatic calcification.
    Alfrey AC
    Kidney Int Suppl; 2004 Sep; (90):S13-7. PubMed ID: 15296502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiological aspects of vascular calcification in chronic renal failure.
    Drüeke TB
    Nefrologia; 2005; 25 Suppl 2():96-9. PubMed ID: 16050411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
    Mehrotra R
    J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular calcification--a matter of damage limitation?
    Shanahan CM
    Nephrol Dial Transplant; 2006 May; 21(5):1166-9. PubMed ID: 16522660
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effects of changes in phosphocalcic metabolism in ocular tissues in patients with chronic hemodialysis].
    Ciocâlteu AM
    Oftalmologia; 2008; 52(1):18-21. PubMed ID: 18714485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathogenesis and therapy for vascular calcification in patients on chronic hemodialysis].
    Nitta K
    Clin Calcium; 2005 Jul; 15(7):106-14. PubMed ID: 15995305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of calcium, phosphorus and bone metabolism in dialysis patients using sevelamer hydrochloride and vitamin D therapy.
    Ishida M; Yao N; Yachiku S; Anzai T; Kobayashi T; Ishida H
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S16-21. PubMed ID: 16109136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular calcification in uremic conditions: new insights into pathogenesis.
    Cozzolino M; Gallieni M; Brancaccio D
    Semin Nephrol; 2006 Jan; 26(1):33-7. PubMed ID: 16412823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.